Case 13.

Phenotypic expression (A), redirected cytotoxicity against P-815 target cells (B), and proliferative activity (C) in the presence of mAbs to CD30, CD30L, CD40, CD40L, CD70, CD95, and CD95L in a representative CD3⁺TCRγδ⁺ patient (case 13). The experimental conditions were the same as in Figure 1.